As of Friday close, Sotera Health Company’s (NASDAQ:SHC) stock was up $0.17, moving up 1.06 percent to $16.22. The average number of shares traded per day over the past five days has been 604,240 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.79 fall in that time frame. In the last twenty days, the average volume was 865,770, while in the previous 50 days, it was 1,027,116.
Since last month, SHC stock retreated -14.13%. Shares of the company fell to $15.82 on 08/03/23, the lowest level in the past month. A 52-week high of $19.85 was reached on 07/19/23 after having rallying from a 52-week low of $5.78. Since the beginning of this year, SHC’s stock price has risen by 94.72% or $7.89, and marked a new high 7 times. However, the stock has declined by -18.29% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
The stock’s beta is 2.25. Besides these, the trailing price-to-sales (P/S) ratio of 4.70, the price-to-book (PB) ratio of 10.89.
Financial Health
In the three months ended June 29, Sotera Health Company’s quick ratio stood at 2.50, while its current ratio was 2.70, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 5.46, and the total debt-to-equity ratio was 5.49. On the profitability front, the trailing twelve-month gross margin is 54.20% percent. In the year ended June 29, EBITDA margin amounted to 47.55%, whereas operating margins totaled -19.30%. Based on annual data, SHC earned $557.0 million in gross profit and brought in $1.0 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -6.80%. Return on equity (ROE) for the past 12 months was -61.70%.
In Sotera Health Company’s quarter-end financial report for June 29, it reported total debt of $2.22 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. SHC’s revenue fell -4.73% to $220.59 million during the quarter, while net income inched up to $254.59 million. While analysts expected Sotera Health Company to report $0.17 quarterly earnings, the actual figure was $0.21 per share, beating the consensus estimate by 23.50%. During the quarter, the company generated $104.9 million in EBITDA. The liabilities of Sotera Health Company were 2.66 billion at the end of its most recent quarter ended June 29, and its total debt was $2.32 billion. The value of shareholders’ equity is $282.62 million.
Technical Picture
This quick technical analysis looks at Sotera Health Company’s (SHC) price momentum. With a historical volatility rate of 17.82%, the RSI 9-day stood at 25.93% on 18 August.
With respect to its five-day moving average, the current Sotera Health Company price is down by -4.64% percent or -$0.79. At present, SHC shares trade -14.86% below its 20-day simple moving average and -7.53% percent below its 100-day simple moving average. However, the stock is currently trading approximately +6.36% above its SMA50 and +135.76% above its SMA200.
Stochastic coefficient K was 10.49% and Stochastic coefficient D was 14.71%, while ATR was 0.53. Given the Stochastic reading of 12.38% for the 14-day period, the RSI (14) reading has been calculated as 32.11%. As of today, the MACD Oscillator reading stands at -0.51, while the 14-day reading stands at -0.96.
Analyst Ratings
KeyBanc Capital Markets upgraded its rating on Sotera Health Company (NASDAQ: SHC) to an Overweight in a note to investors on June 26, 2023. The analysts firm previously had a Sector weight rating on the stock.Sotera Health Company (SHC) has been rated Overweight by analysts. According to 0 brokerage firms, SHC is a sell, and 3 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Sotera Health Company stock as buy, with 3 recommending it as overweight.
With a median target price of $20.00, the current consensus forecast for the stock is $18.00 – $23.00. Based on these forecasts, analysts predict Sotera Health Company (SHC) will achieve an average price target of $20.43.
